Cargando…

Fat clearance and conventional fixation identified ypN0 rectal cancers following intermediate neoadjuvant radiotherapy have similar long-term outcomes

BACKGROUND: As a prognostic factor for colorectal cancer, lymph node (LN) status, particularly the number of LN harvested, has been demonstrated to be essential in the evaluation of quality control in terms of surgical specimen. Neoadjuvant chemoradiation, however, decreases the LN harvest. Therefor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Nan, Sun, Ting-Ting, Li, Zhong-Wu, Yao, Yun-Feng, Wang, Lin, Wu, Ai-Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Retrospective Cohort Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815923/ https://www.ncbi.nlm.nih.gov/pubmed/31662826 http://dx.doi.org/10.4251/wjgo.v11.i10.877

Ejemplares similares

Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapy
por: Trotsyuk, Iryna, et al.
Publicado: (2019)

Selective use of adjuvant chemotherapy for rectal cancer patients with ypN0
por: You, Kai-yun, et al.
Publicado: (2014)

The Benefit of Post-Mastectomy Radiotherapy in ypN0 Patients after Neoadjuvant Chemotherapy According to Molecular Subtypes
por: Cho, Won Kyung, et al.
Publicado: (2019)

Nomogram to predict ypN status after chemoradiation in patients with locally advanced rectal cancer
por: Jwa, E, et al.
Publicado: (2014)

Are you treating ypN0 patient with adjuvant abemaciclib?
por: Toss, A., et al.
Publicado: (2023)

Impact of adjuvant chemotherapy on patients with ypT0–2 ypN0 rectal cancer after neoadjuvant chemoradiation: a cohort study from a tertiary referral hospital
por: Galata, Christian, et al.
Publicado: (2018)

Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer
por: Fukada, Ippei, et al.
Publicado: (2016)

The assessment of risk factors for long-term survival outcome in ypN0 patients with rectal cancer after neoadjuvant therapy and radical anterior resection
por: Zeman, Marcin, et al.
Publicado: (2021)

The prognostic differences and the effect of postmastectomy radiotherapy between post‐chemotherapy ypT1‐2ypN1 and de novo pT1‐2N1 breast cancer
por: Yang, Tian, et al.
Publicado: (2023)

The role of postmastectomy radiation in patients with ypN0 breast cancer after neoadjuvant chemotherapy: a meta-analysis
por: Wang, Ke, et al.
Publicado: (2021)

Axillary response and outcome in breast cancer patients after neoadjuvant treatment: The role of radiotherapy in reducing recurrence in ypN0 patients with initially cN+ stage
por: Ren, Xiaoqiu, et al.
Publicado: (2023)

Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients
por: Mei, Shi-Wen, et al.
Publicado: (2020)

Risk factors for long-term survival in patients with ypN+ M0 rectal cancer after radical anterior resection
por: Zeman, Marcin, et al.
Publicado: (2022)

Nomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy
por: Wei, Fang-Ze, et al.
Publicado: (2020)

Impact factors of lymph node retrieval on survival in locally advanced rectal cancer with neoadjuvant therapy
por: Mei, Shi-Wen, et al.
Publicado: (2020)

Critical prognostic value of the log odds of negative lymph nodes/tumor size in rectal cancer patients
por: Xie, Jie-Bin, et al.
Publicado: (2021)

Consolidation chemotherapy with capecitabine after neoadjuvant chemoradiotherapy in high-risk patients with locally advanced rectal cancer: Propensity score study
por: Sheng, Xue-Qing, et al.
Publicado: (2022)

Evaluating the benefit of adjuvant chemotherapy in patients with ypT0–1 rectal cancer treated with preoperative chemoradiotherapy
por: Jeon, Ye Won, et al.
Publicado: (2021)

The impact of postmastectomy radiotherapy on cT1-2N1 breast cancer patients with ypN0 after neoadjuvant chemotherapy: a retrospective study based on real-world data
por: Dai, Yuran, et al.
Publicado: (2023)

Trends with neoadjuvant radiotherapy and clinical staging for those with rectal malignancies
por: Reddy, Sanjay S, et al.
Publicado: (2017)

Duration of Perioperative Chemotherapy in Locally Advanced Gastric Cancer: A “Less Is More” Question When ypN0 Is Achieved
por: Liu, Zining, et al.
Publicado: (2021)

Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis
por: Piñero, Federico, et al.
Publicado: (2019)

Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study
por: Lei, Xue-Fen, et al.
Publicado: (2018)

Prediction of Advanced Axillary Lymph Node Metastases (ypN2-3) Using Breast MR imaging and PET/CT after Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma Patients
por: Kim, Won Hwa, et al.
Publicado: (2018)

Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer
por: Cai, Du, et al.
Publicado: (2019)

Predictive factors of histological response of colorectal liver metastases after neoadjuvant chemotherapy
por: Serayssol, Chloé, et al.
Publicado: (2019)

Clinical efficacy of gemcitabine and cisplatin-based transcatheter arterial chemoembolization combined with radiotherapy in hilar cholangiocarcinoma
por: Zheng, Wen-Heng, et al.
Publicado: (2019)

Postoperative radiotherapy improves survival of patients with ypN2 non‐small cell lung cancer after neoadjuvant chemotherapy followed by surgery – A propensity score matching study of the Surveillance, Epidemiology, and End Results database
por: Bao, Yongxing, et al.
Publicado: (2021)

Levothyroxine therapy and impaired clearance are the strongest contributors to small intestinal bacterial overgrowth: Results of a retrospective cohort study
por: Brechmann, Thorsten, et al.
Publicado: (2017)

Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy
por: Liu, Zi-Ning, et al.
Publicado: (2021)

Nomogram to predict permanent stoma in rectal cancer patients after sphincter-saving surgery
por: Kuo, Chih-Yu, et al.
Publicado: (2022)

Tumor-stroma ratio as prognostic factor for survival in rectal adenocarcinoma: A retrospective cohort study
por: Scheer, René, et al.
Publicado: (2017)

Intraoperative intraperitoneal chemotherapy increases the incidence of anastomotic leakage after anterior resection of rectal tumors
por: Wang, Zhi-Jie, et al.
Publicado: (2019)

Low ligation has a lower anastomotic leakage rate after rectal cancer surgery
por: Chen, Jia-Nan, et al.
Publicado: (2020)

Contemporary, national patterns of surgery after preoperative therapy for stage II/III rectal adenocarcinoma
por: Soriano, Celine, et al.
Publicado: (2022)

All-epiphyseal versus trans-epiphyseal screw fixation for tillaux fractures: Does it matter?
por: Heldt, Brett, et al.
Publicado: (2022)

Trans-anal minimally invasive surgery for rectal neoplasia: Experience from single tertiary institution in China
por: Chen, Nan, et al.
Publicado: (2018)

Pelvic exenterations for primary rectal cancer: Analysis from a 10-year national prospective database
por: Pellino, Gianluca, et al.
Publicado: (2018)

Value of macrobiopsies and transanal endoscopic microsurgery in the histological work-up of rectal neoplasms: A retrospective study
por: Bökkerink, Guus M J, et al.
Publicado: (2017)

Excision of malignant and pre-malignant rectal lesions by transanal endoscopic microsurgery in patients under 50 years of age
por: Shilo Yaacobi, Dafna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nmkrtld7dvfml8kjc86skdh5e6